Abstract:Background: MicroRNA-155-5p (miR-155-5p) has been reported to play an oncogenic role in different human malignancies; however, its role in Wilms tumor (WT) remains unclear. Methods: Differentially expressed miRNAs (DE-miRNAs) and mRNAs (DEGs) in WT blood and tissues were identified by using miRNA microarray and RNA-sequencing. Bioinformatics prediction and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used to predict the potential functions of DE-miRNAs. DE-miRNAs and DEGs in WT obtained from Gene Expression Omnibus (GEO) and Therapeutically Applicable Research to Generate Effective Treatments (TARGET) were identified by using the "edgeR" package. RT-qPCR was used to explore miR-155-5p and IGF2 expression and their clinical significance in WT specimens. A rhabdoid cell line (G401) and Ewing sarcoma cell line (SK-NEP-1) were used. Immunohistochemical staining, western blotting and dual-luciferase reporter assays were performed to study the mechanisms involved. The CCK-8, flow cytometry, wound healing and transwell assays were performed to identify the effects of miR-155-5p and IGF2 knockdown on cell proliferation, apoptosis, migration and invasion, respectively. Results: MiR-155-5p was downregulated in both blood and tissues from WT patients who did not receive chemotherapy before surgery but was upregulated in tissues from WT patients who had received chemotherapy before surgery. IGF2, PI3K, AKT and mTOR were found to be upregulated in WT tissues. Additionally, miR-155-5p and IGF2 were significantly correlated with TNM stage and lymphatic metastasis in WT patients. Molecular mechanism exploration indicated that IGF2 was downregulated by miR-155-5p via direct binding to its 3' untranslated region in cell lines. Furthermore, IGF2, PI3K, AKT and mTOR expression was inversely correlated with miR-155-5p expression, and PI3K, AKT and mTOR expression was positively correlated with IGF2 expression in cell culture. Functional studies demonstrated that miR-155-5p upregulation and IGF2 knockdown suppressed cell proliferation, migration and invasion and induced cell apoptosis. Moreover, the tumor-suppressing effects of miR-155-5p in cells were abrogated by miR-155-5p inhibitor treatment. Conclusions: Taken together, these findings suggest that miR-155-5p functions as a tumor suppressor in WT through inactivating the PI3K/AKT/mTOR signaling pathway by directly targeting IGF2. Thus, miR-155-5p might be a novel therapeutic target for WT.

Participations of TGFBRl and FGF9 in the Process of Mirna-140-5p Suppressing the Proliferation of Wilms’ Tumor

[Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells in vitro].

MiR-155-5p Exerts Tumor-Suppressing Functions in Wilms Tumor by Targeting IGF2 Via the PI3K Signaling Pathway.

Silencing of Lncrna MEG8 Represses the Viability, Migration, and Invasion of Wilms’ Tumor Cells Through Mediating Mir-23A-3p/crk Axis

MiR-22-3p Regulates the Proliferation and Invasion of Wilms' Tumor Cells by Targeting AKT3.

[Down-Regulation of Lncrna TTTY15 Targeting Mir-4500 to Inhibit the Biological Characteristics of A172 Glioma Cells].

MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms’ Tumor Cell by Targeting PBOV1

Mir-196B Directly Targets Both HOXA9/MEIS1 Oncogenes and FAS Tumour Suppressor in MLL-rearranged Leukaemia.

Effect of miR-590-3p/DKK1 Axis on the Progression of Wilms' Tumour

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

miR-378c suppresses Wilms tumor development via negatively regulating CAMKK2

circ0093740 Promotes Tumor Growth and Metastasis by Sponging miR-136/145 and Upregulating DNMT3A in Wilms Tumor

Long Non-Coding RNA HOTAIRM1 Promotes Proliferation and Inhibits Apoptosis of Glioma Cells by Regulating the Mir-873-5p/zeb2 Axis

Overexpression of Microrna-939-5p Contributes to Cell Proliferation and Associates Poor Prognosis in Glioma.

MiR‐372‐3p Promotes Cell Growth and Metastasis by Targeting FGF9 in Lung Squamous Cell Carcinoma

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1

Long Non-Coding RNA XIST Promotes Wilms Tumor Progression Through the Mir-194-5p/yap Axis.

HnRNPL Promotes Wilms Tumor Progression by Regulating the P53 and Bcl2 Pathways.

Comprehensive Profiling of Novel Microrna-9 Targets and a Tumor Suppressor Role of Microrna-9 Via Targeting IGF2BP1 in Hepatocellular Carcinoma

Mechanism of LncRNA FTX regulates nephroblastoma progression through MiR-215-5p/PI3K/AKT axis

RNA Sequencing Reveals a Regulatory Network of Circrna-Mirna-mrna Cerna in Wilms Tumor